Renflexis
Renflexis (infliximab-abda) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically it is a tumor necrosis factor (TNF) blocker used for many chronic inflammatory conditions. Renflexis is a biosimilar to Remicade.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER: Merck |
CLASS: Biologics (TNF blockers) |
WHAT IT TREATS:
|
PRESCRIBED BY:
|
HOW ADMINISTERED: IV infusion |
FREQUENCY: Three times in the first six weeks, then every 8 weeks |
Length of infusion: About two hours |